Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 484

1.

Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.

Björnsson E, Abrahamsson H, Simrén M, Mattsson N, Jensen C, Agerforz P, Kilander A.

Aliment Pharmacol Ther. 2006 Sep 15;24(6):945-54.

2.

Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.

Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M.

J Gastroenterol Hepatol. 2007 May;22(5):639-44.

PMID:
17444849
4.

On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial.

Lind T, Havelund T, Lundell L, Glise H, Lauritsen K, Pedersen SA, Anker-Hansen O, Stubberöd A, Eriksson G, Carlsson R, Junghard O.

Aliment Pharmacol Ther. 1999 Jul;13(7):907-14.

5.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

6.
7.

Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study.

Nocon M, Labenz J, Jaspersen D, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P, Willich SN.

Aliment Pharmacol Ther. 2007 Mar 15;25(6):715-22.

8.

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.

Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G.

Am J Gastroenterol. 2000 Feb;95(2):395-407.

PMID:
10685741
9.

Review article: alternative approaches to the long-term management of GERD.

Fennerty MB.

Aliment Pharmacol Ther. 2005 Dec;22 Suppl 3:39-44. Review.

10.
11.

Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration.

Hassall E, Kerr W, El-Serag HB.

J Pediatr. 2007 Mar;150(3):262-7, 267.e1.

PMID:
17307542
12.
13.
14.

Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up.

Mehta S, Bennett J, Mahon D, Rhodes M.

J Gastrointest Surg. 2006 Nov;10(9):1312-6; discussion 1316-7.

PMID:
17114017
15.

Review article: treatment of mild and severe cases of GERD.

Tytgat GN.

Aliment Pharmacol Ther. 2002 Jul;16 Suppl 4:73-8. Review.

16.

A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia.

Rabeneck L, Souchek J, Wristers K, Menke T, Ambriz E, Huang I, Wray N.

Am J Gastroenterol. 2002 Dec;97(12):3045-51.

PMID:
12492188
17.

Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.

Higginbotham TW.

Ann Pharmacother. 2010 Mar;44(3):572-6. doi: 10.1345/aph.1M519. Review.

PMID:
20124466
18.

Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.

Gasiorowska A, Navarro-Rodriguez T, Wendel C, Krupinski E, Perry ZH, Koenig K, Moty B, Powers J, Fass R.

Am J Gastroenterol. 2009 Aug;104(8):2005-13. doi: 10.1038/ajg.2009.240.

PMID:
19491829
19.

Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.

Sanduleanu S, Stridsberg M, Jonkers D, Hameeteman W, Biemond I, Lundqvist G, Lamers C, Stockbrügger RW.

Aliment Pharmacol Ther. 1999 Feb;13(2):145-53.

20.

Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'.

Pace F, Tonini M, Pallotta S, Molteni P, Porro GB.

Aliment Pharmacol Ther. 2007 Jul 15;26(2):195-204. Review.

Items per page

Supplemental Content

Support Center